[Melanostatin (MIF-1): central action and clinical use].
D000978:Antiparkinson Agents; D001921:Brain / Q000166:cytology*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D009075:MSH Release-Inhibiting Hormone / Q000502:physiology* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*
D000978:Antiparkinson Agents; D006728:Hormones; D011954:Receptors, Dopamine; D009075:MSH Release-Inhibiting Hormone
Melanostatyna (MIF-1): działania ośrodkowe i próby kliniczne.